Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust

3 Respiratory system
03-04-02 Omalizumab

Omalizumab Xolair®
Prefilled syringe: 75mg/0.5ml, 150mg/1ml

Review effectiveness after 16 weeks of commencing treatment
Link  NICE TA 278: Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201)
Link  NICE TA 339: Omalizumab for previously treated chronic spontaneous urticaria

Red View adult BNF  View SPC online  HCD

Vials: 25mg, 100mg

Link  NICE TA 479: Reslizumab for treating severe eosinophilic asthma

Red View adult BNF  View SPC online